返回
Guangzhou Innogen Pharmaceutical Group Co., Ltd（02591.HK）价格
02591.HK 股价走势图
INNOGEN-B (02591.HK)
Guangzhou Innogen Pharmaceutical Group Co., Ltd
HK$30.98
-3.18%
$-1.01
休市： Jan 16, 16:00:00 HKT
关键数据
前收盘价
$31.02
开盘价
$32
当日区间
$30.86 - $32.78
52周范围
$28.4 - $74
交易量
410.8K
平均成交量
667.1K
每股收益（TTM）
-0.54
股息收益率
--
市值
$13.0B
什么是 INNOGEN-B？
Guangzhou Innogen Pharmaceutical Group Co., Ltd. engages in the production and distribution of pharmaceutical products. The company is headquartered in Guangzhou, Guangdong and currently employs 105 full-time employees. The company went IPO on 2025-08-15. The firm is primarily engaged in the commercialization of innovative, humanized, long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. The firm is dedicated to developing therapies for diabetes and other metabolic diseases. The Company’s core product, Efsubaglutide Alfa (brand name: Diabegone), is used for the treatment of type 2 diabetes (T2D). The Company’s primary pipeline drug candidates include YN014, YN401, YN209, YN203, and YN202. The firm principally conducts its businesses in the domestic market.